Research and Markets: Biomarkers in Alzheimer's Disease - Market Overview Report

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/sl6r47/biomarkers_in) has announced the addition of the "Biomarkers in Alzheimer's Disease - Overview " report to their offering.

Biomarkers have been a heavily studied topic of interest, and recently on the rise is the interest in neurodegenerative disorders, particularly Alzheimer's Disease. Although there are many techniques used to track neurodegenerative disease progression, this report will primarily focus on blood-based and cerebrospinal fluid-based biomarkers for this disease. In addition to covering extensive background information, this report will also highlight market growth and outlook, and feature clinical trial and pipeline information.

Biomarkers in Alzheimer's Disease is focused on biomarker identification and development in patients with Alzheimer's Disease. This report focuses on the Alzheimer's Disease space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With regards to employing the use of biomarkers for Alzheimer's Disease, Biomarkers in Alzheimer's Disease captures market growth of biomarkers, advantages, disadvantages, and validation techniques.

Also available in this report is extensive survey data exclusively conducted for this report. Illustrated by 30 figures captured in an in-depth analysis, this section features insight into targets under investigation, challenges, advantages, and desired features of future diagnostic applications.

Finally, this report comes with clinical trial and pipeline data featuring targets and products from over 200 companies working in Alzheimer's Disease.

Key Topics Covered:

Chapter 1: The Focus of this Report

Chapter 2: Biomarkers and Their Clinical Utility

Chapter 3: Biomarkers in Neurodegenerative Disorders

Chapter 4: Mild Cognitive Impairment and Alzheimer's Disease

Chapter 5: Biomarkers for Diagnostics

Chapter 6: Survey Results

Chapter 7: Clinical Trials and Pipeline Information

For more information visit http://www.researchandmarkets.com/research/sl6r47/biomarkers_in

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices